From photomorphogenesis to cancer: a CSN journey.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Complex assembly and activity states as multifaceted protein attributes explaining phenotypic variability.Molecular systems biology · 2026
   Article
2. Complex Assembly and Activity States as Multifaceted Protein Attributes Explaining Phenotypic Variability.bioRxiv : the preprint server for biology · 2025
   Article
3. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.Oncotarget · 2015
   Article
4. CSN6 deregulation impairs genome integrity in a COP1-dependent pathway.Oncotarget · 2015
   Article
5. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.Cell cycle (Georgetown, Tex.) · 2015
   Article
6. CSN6 positively regulates c-Jun in a MEKK1-dependent manner.Cell cycle (Georgetown, Tex.) · 2015
   Article

Corrections and comments

• Comment on
  CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as